Clinical Trial Update: Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department [NA]

View source ↗

Summary

A clinical trial evaluating early high-flow oxygen therapy combined with a vibrating-mesh nebulized beta-2 agonist for moderate to severe asthma exacerbations i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Poitiers University Hospital | Conditions: Moderate Asthma Exacerbation, Severe Asthma Exacerbation | NA | Status: RECRUITING